Legacy Pharmaceutical Packaging, a contract packager serving the global pharmaceutical industry with bottling, blistering, pouching, unit-of-use, compliance and secondary packaging services, has appointed Steve Meeker as President. Mr. Meeker, who had been the company’s Chief Operating Officer, assumed the new role as of May 1.
A 40-year veteran of the pharmaceutical industry, Mr. Meeker has been with Legacy Packaging for nearly two years. Previously he has held senior leadership roles at such stalwarts as Bayer Healthcare, Sanofi and Marion Merrell Dow.
As President, Meeker will oversee budgets, ensure that resources are installed and aligned, help set and maintain the company’s long-term goals and strategies, and manage overall accountability to shareholders.
For Legacy Packaging, Mr. Meeker’s promotion comes during a time of significant investment and growth. In 2014, the company moved into a modernized 190,000-sq.-foot production facility, and has been steadily incorporating new pieces of equipment to bolster its production and customer servicing capabilities. Recently added machines include a P100 Cartoner from Serpa and a Cremer CFI-622 counting and bottle filling system. Legacy also installed a new cage to its Drug Enforcement Administration-approved Schedule II vault, which holds up to 300 pallets of product. The DEA vault fully meets federal regulation code 21CFR 1301.72, the governing specification for pharmaceutical applications.
Dave Spence, CEO of Legacy Pharmaceutical Packaging, says, “Steve has made significant and positive impacts to Legacy’s overall operations during his tenure, and with the company poised for significant growth over the next 3-5 years, we are confident that his talents, technical expertise, and entrepreneurial spirit will increase our market leadership position.”
Brad Rayner, Legacy’s Executive Director of Sales & Marketing and a 12 year shareholder, adds: ”Steve’s experience and technical background, combined with his deep-rooted passion for customer service, is in perfect alignment with Legacy’s guiding principles and our forward-thinking market approach.”
